Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2026 Feb 4;32(2):767. doi: 10.1038/s41591-026-04245-5

Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial

Léna Rivard 1,✉, Paul Khairy 1, Mario Talajic 1, Jean-Claude Tardif 1, Jeffrey S Healey 2, Sandra E Black 3, Jason G Andrade 4, Thalia S Field 5, Isabelle Nault 6, Louis Bherer 1, Fadi Massoud 7, Stanley Nattel 1, Sylvain Lanthier 8, Normand Racine 1, Jean-François Roux 9, Isabelle Greiss 10, Laurent Macle 1, Peter G Guerra 1, Rafik Tadros 1, Hélène Mayrand 11, Gilbert Gosselin 1, David Conen 2, Christian Bocti 9, Céline Chayer 12, Yan Deschaintre 12, Roopinder K Sandhu 13, Jaimie Manlucu 14, Yaariv Khaykin 15, Atul Verma 16, Blandine Mondésert 1, Katia Dyrda 1, Julia Cadrin-Tourigny 1, Bernard Thibault 1, Alexandre Raymond-Paquin 1, Martin Aguilar 1, Judith Brouillette 1, André Roussin 10, Alain Robillard 17, Maxime Tremblay-Gravel 1, Louis-Philippe David 1, Mariève Cossette 18, Ratika Parkash 19, Marie-Claude Guertin 18, Denis Roy 1, on behalf of the BRAIN-AF investigators
PMCID: PMC12920110  PMID: 41639380

Correction to: Nature Medicine 10.1038/s41591-025-04101-y, published online 7 January 2026.

In the version of the article initially published, the members of the BRAIN-AF investigators group appeared in both the main author list and the consortium author list. This has now been corrected in the HTML and PDF versions of the article, so that they only appear in the consortium author list.


Articles from Nature Medicine are provided here courtesy of Nature Publishing Group

RESOURCES